CHS Inc.
NASDAQ:CHSCLAgricultural Farm Products
-$0.05 today
- Market cap
- $294.90M
- Beta
- 0.10
- P/E (TTM)
- 0.0
- EPS (TTM)
- $0.00
- Dividend yield
- 7.37%
Volume 0.12M
Average 0.02M
CHSCL Interest Expense
Cost of servicing the company's debt during the period.
CHS Inc.NASDAQ: CHSCL
Interest Expense · Q2 FY2026 · quarter ended Feb 2026
Interest expense growth accelerates
Q2 FY2026 interest expense of $43.76M rose 73.6% year over year, ahead of the +71.2% change in trailing-twelve-month interest expense. Sequentially, it rose 17.2% from the prior quarter. Over 3 fiscal years it compounded at +6.7% a year.
Context
- Interest expense amounted to 0.4% of revenue in FY2025, up 0.1 pp from a year earlier.
- Interest expense increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +73.6% holds above the trailing-twelve-month pace of +71.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Interest Expense history
USD · from the income statement
- Latest · FY2025
- 146.08M USD
- Year-over-year change
- +40.4%
- 4-year CAGR
- +6.7%
| Period | Period end | Interest Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-08-31 | 146.08M | +40.4% |
| FY2024 | 2024-08-31 | 104.06M | -24.3% |
| FY2023 | 2023-08-31 | 137.44M | +14.3% |
| FY2022 | 2022-08-31 | 120.26M | +6.8% |
| FY2021 | 2021-08-31 | 112.57M | — |
Interest Expense vs competitors
How CHSCL compares with its peers on the latest reported figures
- Peers report in different currencies, so interest expense is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +71.2% is the 5th highest of 10, against a peer median of +61.9%.
- Interest expense amounts to 0.5% of revenue for CHSCL, versus a peer median of 1.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Feb 2026 | $174.33M USD | +71.2% | +6.7% | 0.5% | |
| LTM Mar 2026 | R$170.7M BRL | +80.6% | -29.1% | 31.3% | |
| LTM Apr 2026 | $148.38M USD | -5.7% | +6.9% | 8.2% | |
AFRIForafric Global PLC | LTM Jun 2024 | $6.96M USD | — | +4.6% | 2.1% |
| LTM Mar 2026 | $6.38M USD | -45.2% | +67.6% | 1.5% | |
| LTM Mar 2026 | $4.72M USD | +41.7% | +13.4% | 28.7% | |
| LTM Mar 2026 | ₪2.55M ILS | +77.9% | +80.3% | 0.4% | |
| LTM Mar 2026 | $2.53M USD | -19.9% | -5.9% | 1.1% | |
| LTM Apr 2026 | $2.4M USD | +169.8% | -12.2% | 1.8% | |
SLSNSolesence, Inc. Common Stock | LTM Mar 2026 | $1.02M USD | +61.9% | +34.6% | 1.7% |
| LTM Mar 2026 | $86K USD | +309.5% | -26.7% | 0.0% | |
| Peer median (excluding CHSCL) | — | +61.9% | +5.7% | 1.7% | |
Competitors are the stored peer set for CHSCL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Aug 2021 | FY2022 Aug 2022 | FY2023 Aug 2023 | FY2024 Aug 2024 | FY2025 Aug 2025 |
|---|---|---|---|---|---|
| Revenue | 38.45B | 47.79B | 45.59B | 39.26B | 35.46B |
| Cost of Revenue | 36.57B | 45.1B | 42.81B | 37.51B | 34.33B |
| Gross Profit | 1.88B | 2.69B | 2.78B | 1.75B | 1.14B |
| Gross Margin | 4.9% | 5.6% | 6.1% | 4.5% | 3.2% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 746.71M | 998.41M | 1.03B | 1.15B | 1.05B |
| Operating Expenses | 746.71M | 998.41M | 1.03B | 1.17B | 1.05B |
| Depreciation & Amortization | 461.73M | 461.97M | 464.62M | 481.72M | 651.43M |
| EBITDA | 1.08B | 2.39B | 2.61B | 1.68B | 1.41B |
| EBITDA Margin | 2.8% | 5.0% | 5.7% | 4.3% | 4.0% |
| Operating Income | 1.13B | 1.69B | 1.75B | 584.36M | 90.76M |
| Operating Margin | 2.9% | 3.5% | 3.8% | 1.5% | 0.3% |
| Interest Income | 104.57M | 114.16M | 0 | 0 | 0 |
| Interest Expense | 112.57M | 120.26M | 137.44M | 104.06M | 146.08M |
| Other Income / Expenses | (614.41M) | 115.96M | 257.06M | 513.43M | 524.02M |
| Income Before Tax | 515.32M | 1.81B | 2.01B | 1.1B | 614.77M |
| Pre-Tax Margin | 1.3% | 3.8% | 4.4% | 2.8% | 1.7% |
| Income Tax Expense | (38.25M) | 132.12M | 107.66M | (4.87M) | 16.78M |
| Net Income | 553.95M | 1.68B | 1.9B | 1.1B | 597.92M |
| Net Margin | 1.4% | 3.5% | 4.2% | 2.8% | 1.7% |
| EPS (Basic) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS (Diluted) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares | 0 | 0 | 0 | 0 | 0 |
| Weighted Avg Shares (Diluted) | 0 | 0 | 0 | 0 | 0 |
CHS Inc.
NASDAQ:CHSCL
Intrinsic Alpha fair value
Locked
Current Price
$24.03
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.